Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Aug-24 4:30 PM View:  | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Aug-24 | Payment of Exercise | 2,361 | $0.87 | $2,054.07 | (< 1%) 807.62K to 805.26K | |
| 08-Aug-24 4:29 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Aug-24 | Payment of Exercise | 876 | $0.87 | $762.12 | (< 1%) 178.25K to 177.37K | |
| 08-Aug-24 4:33 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Aug-24 | Payment of Exercise | 999 | $0.87 | $869.13 | (1%) 94.92K to 93.92K | |
| 05-Aug-24 4:15 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Aug-24 | Payment of Exercise | 985 | $0.94 | $925.90 | (< 1%) 179.23K to 178.25K | |
| 05-Aug-24 4:15 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 01-Aug-24 | Payment of Exercise | 1,146 | $0.94 | $1,077.24 | (1%) 96.06K to 94.92K | |
| 05-Aug-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Aug-24 | Payment of Exercise | 2,751 | $0.94 | $2,585.94 | (< 1%) 810.37K to 807.62K | |
| 04-Jun-24 6:09 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 03-Jun-24 | Sale (Planned) | 14,645 | $1.39 | $20,356.50 | (13%) 110.71K to 96.06K | |
| 07-May-24 4:15 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-May-24 | Payment of Exercise | 834 | $1.75 | $1,459.50 | (< 1%) 190.24K to 189.4K | |
| 07-May-24 4:15 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-May-24 | Payment of Exercise | 999 | $1.75 | $1,748.25 | (< 1%) 111.71K to 110.71K | |
| 07-May-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-May-24 | Payment of Exercise | 2,361 | $1.75 | $4,131.75 | (< 1%) 812.73K to 810.37K | |
| 07-May-24 4:15 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-May-24 | Payment of Exercise | 875 | $1.75 | $1,531.25 | (< 1%) 180.11K to 179.23K | |
| 03-May-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 2,751 | $1.77 | $4,869.27 | (< 1%) 815.48K to 812.73K | |
| 03-May-24 4:15 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 985 | $1.77 | $1,743.45 | (< 1%) 181.09K to 180.11K | |
| 03-May-24 4:15 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 917 | $1.77 | $1,623.09 | (< 1%) 191.15K to 190.24K | |
| 03-May-24 4:15 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 01-May-24 | Payment of Exercise | 1,146 | $1.77 | $2,028.42 | (1%) 112.85K to 111.71K | |
| 05-Mar-24 4:15 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 5,576 | $2.27 | $12,657.50 | (3%) 186.67K to 181.09K | |
| 05-Mar-24 4:15 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 6,310 | $2.27 | $14,323.70 | (3%) 197.46K to 191.15K | |
| 05-Mar-24 4:15 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Mar-24 | Payment of Exercise | 12,657 | $2.27 | $28,731.40 | (2%) 828.14K to 815.48K | |
| 08-Feb-24 5:06 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 985 | $2.32 | $2,285.20 | (< 1%) 198.45K to 197.46K | |
| 08-Feb-24 5:08 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 2,788 | $2.32 | $6,468.16 | (< 1%) 830.92K to 828.14K | |
| 08-Feb-24 5:10 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 1,180 | $2.32 | $2,737.60 | (1%) 114.03K to 112.85K | |
| 08-Feb-24 5:05 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Feb-24 | Payment of Exercise | 1,033 | $2.32 | $2,396.56 | (< 1%) 187.7K to 186.67K | |
| 31-Jan-24 7:35 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 150,000 | -- | -- | 22% 680.92K to 830.92K | |
| 31-Jan-24 7:38 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 62,500 | -- | -- | 121% 51.53K to 114.03K | |
| 31-Jan-24 7:36 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 53,750 | -- | -- | 40% 133.95K to 187.7K | |
| 31-Jan-24 7:34 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 29-Jan-24 | Grant | 50,000 | -- | -- | 34% 148.45K to 198.45K | |
| 08-Nov-23 4:14 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 876 | $1.82 | $1,594.32 | (< 1%) 134.83K to 133.95K | |
| 08-Nov-23 4:12 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 834 | $1.82 | $1,517.88 | (< 1%) 146.48K to 145.65K | |
| 08-Nov-23 4:13 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 2,361 | $1.82 | $4,297.02 | (< 1%) 683.29K to 680.92K | |
| 08-Nov-23 4:10 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Nov-23 | Payment of Exercise | 999 | $1.82 | $1,818.18 | (2%) 52.53K to 51.53K | |
| 06-Sep-23 4:31 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 6,310 | $2.67 | $16,847.70 | (4%) 152.79K to 146.48K | |
| 06-Sep-23 4:28 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 12,657 | $2.67 | $33,794.20 | (2%) 695.94K to 683.29K | |
| 06-Sep-23 4:29 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Sep-23 | Payment of Exercise | 5,576 | $2.67 | $14,887.90 | (4%) 140.4K to 134.83K | |
| 09-Aug-23 4:29 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 2,361 | $2.67 | $6,303.87 | (< 1%) 698.3K to 695.94K | |
| 09-Aug-23 4:38 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 875 | $2.67 | $2,336.25 | (< 1%) 141.28K to 140.4K | |
| 09-Aug-23 4:31 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 999 | $2.67 | $2,667.33 | (2%) 53.53K to 52.53K | |
| 09-Aug-23 4:37 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 07-Aug-23 | Payment of Exercise | 834 | $2.67 | $2,226.78 | (< 1%) 153.63K to 152.79K | |
| 10-May-23 4:18 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 875 | $4.14 | $3,622.50 | (< 1%) 142.15K to 141.28K | |
| 10-May-23 4:14 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 969 | $4.14 | $4,011.66 | (2%) 54.5K to 53.53K | |
| 10-May-23 4:16 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 834 | $4.14 | $3,452.76 | (< 1%) 154.46K to 153.63K | |
| 10-May-23 4:19 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 08-May-23 | Payment of Exercise | 2,361 | $4.14 | $9,774.54 | (< 1%) 700.66K to 698.3K | |
| 02-Mar-23 6:39 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 12,657 | $5.51 | $69,740.10 | (2%) 713.32K to 700.66K | |
| 02-Mar-23 6:37 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 5,576 | $5.51 | $30,723.80 | (4%) 147.73K to 142.15K | |
| 02-Mar-23 6:35 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 01-Mar-23 | Payment of Exercise | 6,310 | $5.51 | $34,768.10 | (4%) 160.77K to 154.46K | |
| 08-Feb-23 4:18 PM View: | Chakraborty Tirtha Chief Scientific Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 47,750 | -- | -- | 48% 99.98K to 147.73K | |
| 08-Feb-23 4:22 PM View: | Jorgensen Nathan D. Chief Financial Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 45,500 | -- | -- | 39% 115.27K to 160.77K | |
| 08-Feb-23 4:23 PM View: | Attar Eyal C. Chief Medical Officer | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 54,500 | -- | -- | 100% 0 to 54.5K | |
| 08-Feb-23 4:28 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 06-Feb-23 | Grant | 128,750 | -- | -- | 22% 584.57K to 713.32K | |
| 09-Dec-22 4:32 PM View: | Ra Capital Management, LLC Director 10% Owner | Vor Biopharma Inc. (VOR) | 09-Dec-22 | Grant | 11,627,900 | $4.30 | $50,000,000.00 | 105% 11.12M to 22.75M | |
| 15-Sep-22 4:18 PM View: | Ang Robert President and CEO Director | Vor Biopharma Inc. (VOR) | 13-Sep-22 | Grant | 172,500 | -- | -- | 42% 412.07K to 584.57K |
